DIA/EFGCP/EMA better medicines for children annual conference, Londen

Nearing a decade of the European Union (EU) Paediatric Regulation, with close to 2,000 submitted paediatric investigation plans, paediatric needs are recognised as an integrated part of drug development with the inclusion of children now accepted as standard procedure. However, challenges remain, which can result in delayed access by children to innovative medicines. This year’s joint Drug Information Association (DIA)/ European Forum for Good Clinical Practice (EFGCP)/ European Medicines Agency (EMA) annual paediatric conference will focus on ways to overcome these challenges, such as through collaboration, extrapolation, modelling & simulation and adaptive pathways. The conference will provide an opportunity to interact with EMA paediatric coordinators, members of the Paediatric Committee and other stakeholders interested in paediatric drug development. Patients’ and Healthcare professionals’ views will complement the reports of practical experience.